The purpose of this study to compare the typically prescribed dose of metformin (1000mg twice
a day) with a higher dose of metformin (1350mg twice a day).
Phase:
Early Phase 1
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)